作为新兴抗癌剂的亚醇 - 黄类杂交物:以生物活性为重点的审查
Mihaela Lipovanu1, Anca Miron1, Nina Filip1
1Grigore T. Popa University of Medicine and Pharmacy Iasi, 16, Universitatii Street, 700115 Iasi, Romania.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
亚醇和黄类的分子杂交产生了新的抗癌药物. 这些混合体显示出增强的功效,多目标活性和对抗抗性癌细胞的有效性,提供了新的治疗途径.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 有机合成 有机合成
背景情况:
- 癌症治疗面临挑战,包括有限的疗效,特异性,副作用和耐药性.
- 分子杂交提供了一种策略,通过结合多个生物活性分子来克服这些局限性.
- 亚和黄因因其个别的抗癌性质而闻名,使它们成为混合化的合适候选者.
研究的目的:
- 审查醇 - 黄类混合物的合成和抗癌潜力.
- 为了突出这些混合体在现有疗法上的优势.
- 讨论结构-活性关系,以优化药物设计.
主要方法:
- 对已报告抗癌活性的醇-黄类杂交物进行全面的文献搜索.
- 对合成混合物的分析,重点是三醇 - ,三醇 - 黄和其他醇 - 黄类基架.
- 报告的抗瘤功效,多目标效应,细胞毒性和耐药性概况的评估.
主要成果:
- 已经合成和研究了250多种醇 - 黄类杂交物.
- 与参考药物相比,许多杂交药物表现出优越的抗瘤功效.
- 这些混合体表现出多目标活性,瘤选择性细胞毒性和对抗耐药癌细胞的有效性.
结论:
- 亚醇 - 黄类混合物代表了一类有前途的化合物,用于开发新型抗癌药物.
- 它们的多重准能力和对抗抗性细胞的有效性提供了显著的治疗潜力.
- 对结构-活性关系的进一步研究可以指导设计更强效和选择性的抗癌剂.
相关概念视频
Cancer Prevention
8.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.3K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
54
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
54
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K

